- ►bmj.com [PDF] K Allegaert, V Cossey, G Naulaers, C Vanhole, … - British Medical Journal, 2004 - bjo.bmj.com Corticosteroid therapy, given orally or intravenously, is the standard treatment
for GCA associated visual loss. 1 The optimal route of administration and dosage
to pre- vent further visual loss are not known; however, most clinicians ... Related articles - All 9 versions
ZZ Chen, WW Jia, PLP Kaufman, PLP … - Current Eye Research, 1999 - informahealthcare.com 1Department of Ophthalmology, University of British Columbia, Vancouver, BC,
Canada; 2Department of Ophthalmology and Visual Sciences, and 3Wisconsin
Regional Primate Research Center, University of Wisconsin-Madison, WI, USA Cited by 6 - Related articles - BL Direct - All 6 versions
- ►bmj.com [PDF] GM Saleh - British Medical Journal, 2004 - bjo.bmj.com Corticosteroid therapy, given orally or intravenously, is the standard treatment
for GCA associated visual loss. 1 The optimal route of administration and dosage
to pre- vent further visual loss are not known; however, most clinicians ... Cited by 1 - Related articles - All 7 versions
- ►bmj.com [PDF] A Churchill - British Medical Journal, 2004 - bjo.bmj.com Corticosteroid therapy, given orally or intravenously, is the standard treatment
for GCA associated visual loss. 1 The optimal route of administration and dosage
to pre- vent further visual loss are not known; however, most clinicians ... Related articles - All 4 versions
L Dragan - British Medical Journal, 2004 - bjo.bmj.com Corticosteroid therapy, given orally or intravenously, is the standard treatment
for GCA associated visual loss.1 The optimal route of administration and dosage
to pre- vent further visual loss are not known; however, most clinicians ... Related articles - All 4 versions
- ►bmj.com [PDF] J Olver - British Medical Journal, 2004 - bjo.bmj.com Corticosteroid therapy, given orally or intravenously, is the standard treatment
for GCA associated visual loss. 1 The optimal route of administration and dosage
to pre- vent further visual loss are not known; however, most clinicians ... Related articles - All 4 versions
- ►bmj.com [PDF] U Bhatt - British Medical Journal, 2004 - bjo.bmj.com Corticosteroid therapy, given orally or intravenously, is the standard treatment
for GCA associated visual loss. 1 The optimal route of administration and dosage
to pre- vent further visual loss are not known; however, most clinicians ... Cited by 2 - Related articles - All 8 versions
- ►bmj.com [PDF] JC Rucker, V Biousse, NJ Newman - British Medical Journal, 2004 - bjo.bmj.com Corticosteroid therapy, given orally or intravenously, is the standard treatment
for GCA associated visual loss. 1 The optimal route of administration and dosage
to pre- vent further visual loss are not known; however, most clinicians ... Cited by 17 - Related articles - All 8 versions
- ►bmj.com [PDF] IM MacDonald, M Hebert, RJ Yau, S Flynn, J … - British Medical Journal, 2004 - bjo.bmj.com Corticosteroid therapy, given orally or intravenously, is the standard treatment
for GCA associated visual loss. 1 The optimal route of administration and dosage
to pre- vent further visual loss are not known; however, most clinicians ... Cited by 9 - Related articles - All 10 versions
- ►bmj.com [PDF] M Tomita, T Matsubara, H Yamada, K … - British Medical Journal, 2004 - bjo.bmj.com Corticosteroid therapy, given orally or intravenously, is the standard treatment
for GCA associated visual loss. 1 The optimal route of administration and dosage
to pre- vent further visual loss are not known; however, most clinicians ... Cited by 9 - Related articles - All 7 versions
